172 related articles for article (PubMed ID: 26579130)
1. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.
Gunther S; Ostheimer C; Stangl S; Specht HM; Mozes P; Jesinghaus M; Vordermark D; Combs SE; Peltz F; Jung MP; Multhoff G
Front Immunol; 2015; 6():556. PubMed ID: 26579130
[TBL] [Abstract][Full Text] [Related]
2. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
Specht HM; Ahrens N; Blankenstein C; Duell T; Fietkau R; Gaipl US; Günther C; Gunther S; Habl G; Hautmann H; Hautmann M; Huber RM; Molls M; Offner R; Rödel C; Rödel F; Schütz M; Combs SE; Multhoff G
Front Immunol; 2015; 6():162. PubMed ID: 25926832
[TBL] [Abstract][Full Text] [Related]
3. Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer.
Seier S; Bashiri Dezfouli A; Lennartz P; Pockley AG; Klein H; Multhoff G
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428793
[TBL] [Abstract][Full Text] [Related]
4. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
[TBL] [Abstract][Full Text] [Related]
5. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
6. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells.
Hromadnikova I; Li S; Kotlabova K; Dickinson AM
PLoS One; 2016; 11(3):e0151535. PubMed ID: 26982331
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
Moser C; Schmidbauer C; Gürtler U; Gross C; Gehrmann M; Thonigs G; Pfister K; Multhoff G
Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
[TBL] [Abstract][Full Text] [Related]
8. Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Multhoff G; Seier S; Stangl S; Sievert W; Shevtsov M; Werner C; Pockley AG; Blankenstein C; Hildebrandt M; Offner R; Ahrens N; Kokowski K; Hautmann M; Rödel C; Fietkau R; Lubgan D; Huber R; Hautmann H; Duell T; Molls M; Specht H; Haller B; Devecka M; Sauter A; Combs SE
Clin Cancer Res; 2020 Oct; 26(20):5368-5379. PubMed ID: 32873573
[TBL] [Abstract][Full Text] [Related]
9. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.
Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G
Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482
[TBL] [Abstract][Full Text] [Related]
10. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
Bashiri Dezfouli A; Yazdi M; Benmebarek MR; Schwab M; Michaelides S; Miccichè A; Geerts D; Stangl S; Klapproth S; Wagner E; Kobold S; Multhoff G
Front Immunol; 2022; 13():883694. PubMed ID: 35720311
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study.
Yazdi M; Hasanzadeh Kafshgari M; Khademi Moghadam F; Zarezade V; Oellinger R; Khosravi M; Haas S; Hoch CC; Pockley AG; Wagner E; Wollenberg B; Multhoff G; Bashiri Dezfouli A
Adv Sci (Weinh); 2024 Apr; 11(14):e2305998. PubMed ID: 38298098
[TBL] [Abstract][Full Text] [Related]
12. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
Gross C; Hansch D; Gastpar R; Multhoff G
Biol Chem; 2003 Feb; 384(2):267-79. PubMed ID: 12675520
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
Milani V; Stangl S; Issels R; Gehrmann M; Wagner B; Hube K; Mayr D; Hiddemann W; Molls M; Multhoff G
J Transl Med; 2009 Jun; 7():50. PubMed ID: 19549307
[TBL] [Abstract][Full Text] [Related]
14. Role of membrane Hsp70 in radiation sensitivity of tumor cells.
Murakami N; Kühnel A; Schmid TE; Ilicic K; Stangl S; Braun IS; Gehrmann M; Molls M; Itami J; Multhoff G
Radiat Oncol; 2015 Jul; 10():149. PubMed ID: 26197988
[TBL] [Abstract][Full Text] [Related]
15. Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy - potential markers for predicting breast cancer recurrence?
Rothammer A; Sage EK; Werner C; Combs SE; Multhoff G
Radiat Oncol; 2019 May; 14(1):78. PubMed ID: 31077235
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
Gastpar R; Gehrmann M; Bausero MA; Asea A; Gross C; Schroeder JA; Multhoff G
Cancer Res; 2005 Jun; 65(12):5238-47. PubMed ID: 15958569
[TBL] [Abstract][Full Text] [Related]
17. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
18. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
[TBL] [Abstract][Full Text] [Related]
19. Hsp70 in Liquid Biopsies-A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer.
Werner C; Stangl S; Salvermoser L; Schwab M; Shevtsov M; Xanthopoulos A; Wang F; Dezfouli AB; Thölke D; Ostheimer C; Medenwald D; Windberg M; Bache M; Schlapschy M; Skerra A; Multhoff G
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359606
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin.
Ostheimer C; Gunther S; Bache M; Vordermark D; Multhoff G
Front Immunol; 2017; 8():1305. PubMed ID: 29093708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
